Most specialists agree that an early detection of ovarian cancer would prolong the life of those affected, of which only 35% remain alive after five years of diagnosing the disease. However, the reality is that, in Spain, seven out of ten patients who develop this type of cancer are in an advanced stage of the disease when it is finally detected.

The symptomatology that accompanies ovarian cancer is common to other pathologies, especially to diseases of the digestive system, and this is the main reason why it goes unnoticed and, when it is diagnosed, it has frequently spread and affects other neighboring organs.

The symptomatology that accompanies ovarian cancer is common to other pathologies, especially to diseases of the digestive system, so it usually goes unnoticed

The Mutua Madrileña Foundation, with the collaboration of the OncoSur hospital network, has just carried out a study, in which oncologists and gynecologists (a total of 65 specialists) assure that the ovarian cancer prognosis is determined by the stage in which the ovarian cancer is determined. he finds the disease at the time of diagnosis, and most of them think that the survival of the patients could be increased by 20-30% if the tumor was detected early.

In the opinion of Dr. Cristina Grávalos, of the Medical Oncology Service of the Hospital 12 de Octubre in Madrid, at present there are no early detection programs that are effective, so she believes that women should attend a gynecological examination. the years because they can detect symptoms that alert about the possible presence of the pathology.

Although the causes of ovarian cancer are unknown, there are risk factors that increase the chances of developing this pathology, such as Genetic heritage and, in particular, present a mutation of the BRCA1 or BRCA2 gene, or have relatives who have it or have suffered cancer, especially if it is breast, colon or ovarian cancer.

Experts recommend that women in this situation perform regular check-ups starting at age 30, which include tests such as ultrasound Transvaginal evaluation of the CA125 tumor marker. In addition, they consider it essential to inform the population about this type of cancer, and establish an adequate coordination with primary care professionals, who can detect symptoms early and, if they suspect, refer the patient to the specialist.

Advances in Immunotherapy for Ovarian Cancer, with Dr John Liao (November 2019).